Fludarabine
Common brands: Fludarabine, Cyclophosphamide, Frindovyx, Busulfex, Rituxan
Top reporter: Fresenius Kabi Usa, Llc
Alkylating Drug [EPC]Calcineurin Inhibitor Immunosuppressant [EPC]Corticosteroid [EPC]CD20-directed Cytolytic Antibody [EPC]Nucleoside Metabolic Inhibitor [EPC]
38,321
Total Reports
22,151
Serious Reports
11,767
Death Reports
30
Reported Reactions
Death Report Ratio: High (30.71%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Fludarabine.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | OFF LABEL USE | 4,199 | |
| 2 | PYREXIA | 2,897 | |
| 3 | DRUG INEFFECTIVE | 2,896 | |
| 4 | CYTOKINE RELEASE SYNDROME | 2,830 | |
| 5 | FEBRILE NEUTROPENIA | 2,780 | |
| 6 | PRODUCT USE IN UNAPPROVED INDICATION | 2,239 | |
| 7 | NEUTROPENIA | 1,974 | |
| 8 | CYTOMEGALOVIRUS INFECTION | 1,655 | |
| 9 | THROMBOCYTOPENIA | 1,575 | |
| 10 | SEPSIS | 1,506 | |
| 11 | ACUTE GRAFT VERSUS HOST DISEASE | 1,504 | |
| 12 | PNEUMONIA | 1,426 | |
| 13 | MUCOSAL INFLAMMATION | 1,371 | |
| 14 | INFECTION | 1,363 | |
| 15 | PANCYTOPENIA | 1,344 | |
| 16 | GRAFT VERSUS HOST DISEASE | 1,224 | |
| 17 | CYTOMEGALOVIRUS INFECTION REACTIVATION | 1,182 | |
| 18 | DEATH | 1,146 | |
| 19 | ACUTE GRAFT VERSUS HOST DISEASE IN SKIN | 1,104 | |
| 20 | DISEASE PROGRESSION | 1,045 | |
| 21 | ANAEMIA | 1,013 | |
| 22 | DIARRHOEA | 1,012 | |
| 23 | RESPIRATORY FAILURE | 957 | |
| 24 | CHRONIC GRAFT VERSUS HOST DISEASE | 922 | |
| 25 | MYELODYSPLASTIC SYNDROME | 917 | |
| 26 | MULTIPLE ORGAN DYSFUNCTION SYNDROME | 888 | |
| 27 | ACUTE KIDNEY INJURY | 887 | |
| 28 | PLATELET COUNT DECREASED | 844 | |
| 29 | HYPOTENSION | 826 | |
| 30 | NAUSEA | 823 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.